Celyad Oncology SA: key financial figures for fiscal year 2022 (in EUR), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2022)
- €0
- Net Income/Loss (FY2022)
- -€40.9M
- Total Assets (FY2022)
- €19.7M
- Total Equity (FY2022)
- €4.3M
- Cash Flows from Operating Activities (FY2022)
- -€28.0M
Source: Celyad Oncology SA 20-F filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
